Maite del Olmo Basterrechea-rekin lankidetzan egindako argitalpenak (7)

2006

  1. Cytomodulation of interleukin-2 effect by L-2-oxothiazolidine-4-carboxylate on human malignant melanoma

    Cancer Immunology, Immunotherapy, Vol. 55, Núm. 8, pp. 948-957

  2. Influence of the level of γ-glutamyltranspeptidase activity on the response of poorly and moderately differentiated rhabdomyosarcoma cell lines to all-trans-retinoic acid

    Anti-Cancer Drugs, Vol. 17, Núm. 10, pp. 1127-1139

2002

  1. L-2-oxothiazolidine-4-carboxylate reverses the tumour growth-promoting effect of interleukin-2 and improves the anti-tumour efficacy of biochemotherapy in mice bearing B16 melanoma liver metastases

    Melanoma Research, Vol. 12, Núm. 1, pp. 17-26

  2. Role of γ-glutamyltranspeptidase on the response of poorly and moderately differentiated rhabdomyosarcoma cell lines to buthionine sulfoximine-induced inhibition of glutathione synthesis

    Anti-Cancer Drugs, Vol. 13, Núm. 3, pp. 281-291

2000

  1. Effects of L-2-oxothiazolidine-4-carboxylate on the cytotoxic activity and toxicity of cyclophosphamide in mice bearing B16F10 melanoma liver metastases

    Melanoma Research, Vol. 10, Núm. 2, pp. 103-112

  2. Tunicamycin treatment reduces intracellular glutathione levels: Effect on the metastatic potential of the rhabdomyosarcoma cell line S4MH

    Chemotherapy, Vol. 46, Núm. 6, pp. 408-428

1999

  1. In vitro and in vivo comparison between the effects of treatment with adenosine triphosphate and treatment with buthionine sulfoximine on chemosensitization and tumour growth of B16 melanoma

    Melanoma Research, Vol. 9, Núm. 3, pp. 233-242